# A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

> **NCT00683969** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 136 (estimated)

## Conditions studied

- Myasthenia Gravis, Generalized

## Interventions

- **DRUG:** mycophenolate mofetil (CellCept)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00683969
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2008-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683969, "A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00683969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*